PGP
SANA icon

Prescott General Partners’s Sana Biotechnology SANA Stock Holding History

Prescott General Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-122,097
Closed -$785K – 12
2022
Q2 		$785K Sell
122,097
-193,703
-61% -$1.23M 0.05% 10
2022
Q1 		$2.61M Buy
315,800
+295,601
+1,463% +$2.39M 0.12% 11
2021
Q4 		$313K Buy
+20,199
New +$389K 0.01% 14

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Prescott General Partners's SANA Position: Q3 2022 in Review

Prescott General Partners sold out of Sana Biotechnology (SANA) in Q3 2022, closing a stake of 122,097 shares — an estimated $785K sold.

Prescott General Partners first reported a position in SANA in Q4 2021 and held it in 3 quarters. The position peaked at $2.61M in Q1 2022. 125 funds tracked by Wall St. Rank hold SANA as of Q3 2022.

  • Prescott General Partners reported no remaining Sana Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Prescott General Partners sold 122,097 Sana Biotechnology shares in Q3 2022, an estimated $785K.
  • Prescott General Partners first reported a position in Sana Biotechnology in Q4 2021 and held it in 3 quarters.
  • Prescott General Partners's Sana Biotechnology position peaked at $2.61M in Q1 2022.
  • 125 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2022.

Based on Prescott General Partners's 13F filing for Q3 2022, filed 14 Nov 2022.